Instalab
logoInstalab

Calcium Phosphate Saturation

24 Hour Urine Test
A read on calcium phosphate kidney stone risk that goes beyond what a single urine test can show.

Should you take a Calcium Phosphate Saturation test?

This test is most useful if any of these apply to you.

Already Had a Kidney Stone
If you have passed a stone, this test shows whether your urine chemistry is still pushing you toward another one.
Strong Family History of Stones
Stone formation has genetic and dietary patterns that run in families. See your starting risk before symptoms appear.
Living With Hyperparathyroidism or CKD
These conditions reshape urine chemistry. Tracking supersaturation tells you whether stones are an active risk for you.
Healthy but Want to Stay Ahead
If you have risk factors like obesity, gout, or recurrent UTIs, a baseline gives you data to act on before a stone shows up.

About Calcium Phosphate Saturation

If you have ever passed a kidney stone, or watched a family member pass one, you know the pain is unforgettable and the fear of recurrence is real. This number tells you how close your urine is to actively forming the type of stone made of calcium and phosphate, and it does so by combining everything in your urine that pushes you toward stones (calcium, phosphate, alkaline pH) against everything that protects you (citrate, water volume).

It is a calculated index, not a single chemical you can measure with one drop of blood. The value comes from a full day of urine collection processed through software that integrates the major drivers of crystal formation. Higher values mean your urine chemistry is leaning toward stone formation, even if you have never had symptoms.

How This Number Is Calculated

Your kidneys filter calcium, phosphate, citrate, and other minerals into urine throughout the day. When the concentration of calcium and phosphate rises high enough, and when urine pH becomes more alkaline, those minerals start to bind together into the crystals that eventually become stones. Citrate and high urine volume work in the opposite direction, keeping minerals in solution. The supersaturation index pulls all of these inputs together into one number that reflects the crystallization tendency of your urine.

Because the value depends on multiple inputs, two people with identical urine calcium can have very different supersaturation results. One might have plenty of citrate and a healthy urine volume; the other might have low citrate and concentrated urine. The single number captures that combined picture in a way that no individual mineral measurement can.

Kidney Stone Risk

Higher calcium phosphate supersaturation tracks closely with whether someone forms kidney stones. In three large cohorts studied together, people with higher supersaturation values were more likely to be kidney stone formers compared to those with values in the lowest category. The supersaturation index also matches what stones are actually made of: when stones contain more calcium phosphate, the urine supersaturation for calcium phosphate is correspondingly higher.

What this means for you: this number is most useful if you have already had a stone and want to know whether your current urine chemistry is still pushing you toward another one, or if you have a strong family history of stones and want to see your starting risk before symptoms appear.

Stones in the Setting of Other Conditions

Several systemic conditions show up in this number. In primary hyperparathyroidism (an overactive parathyroid gland that drives calcium high), supersaturation drops measurably after the gland is surgically removed, with values falling alongside reductions in urine calcium. As chronic kidney disease progresses, supersaturation tends to fall as urine calcium drops, but the broader stone risk profile shifts in complex ways.

Metabolic syndrome traits track with lower urine pH and higher acid output, which alters the chemistry that drives this number. If you are managing any of these conditions, this test gives you a way to see how the underlying biology is showing up in your urine.

Reference Ranges

One important caveat upfront: supersaturation is a continuous risk index, not a yes-or-no diagnostic test. Different labs use slightly different software algorithms (the most common are EQUIL2 and the Lithorisk system), and values are typically reported as a unitless ratio. The categories below come from published research on kidney stone formers and represent useful orientation rather than universally agreed thresholds.

TierSupersaturation RatioWhat It Suggests
Low riskBelow 1.0Urine is undersaturated; calcium phosphate crystals unlikely to form
Moderate risk1.0 to 2.0Urine approaches saturation; risk is meaningfully higher than baseline
Higher riskAbove 2.0Urine is supersaturated; in cohort data, the odds of being a stone former were higher than in the under 1.0 group

Compare your results within the same lab over time for the most meaningful trend. A shift from 0.4 to 1.5 within the same lab is a real signal even if the absolute numbers look modest.

Why One Reading Is Not Enough

Urine chemistry varies day to day based on what you eat, how much you drink, and many other factors. Studies in adults and children both show that a single 24-hour collection can miss metabolic abnormalities that show up clearly when two or three collections are reviewed together. Pediatric stone formers in particular were under-detected with single collections compared to consecutive ones.

Serial collections months apart also let you see whether changes you make are working. In one cohort of active stone formers, repeat collections at six-month or longer intervals showed measurable improvements in stone risk parameters as people adjusted their habits and treatments. Get a baseline (ideally two collections close together), retest in three to six months if you are making changes, and at least annually thereafter if you are an active stone former or carry risk factors.

What an Abnormal Result Should Make You Do

If your supersaturation comes back elevated, the next step is to look at the components: urine calcium, urine citrate, urine pH, urine volume, and urine sodium. The pattern matters as much as the headline number. High calcium with low citrate and an alkaline pH points toward a different intervention than concentrated low-volume urine alone.

If you have had stones, this is a good time to involve a urologist or nephrologist with stone expertise, especially one who works with metabolic stone clinics. If you have never had a stone but the number is elevated and you have a family history, you can take this to a primary care doctor or directly to a stone-focused specialist. Companion tests worth considering at the same time include a serum calcium and parathyroid hormone (to rule out hyperparathyroidism), a basic kidney function panel, and a stone composition analysis if you have ever passed one and saved it.

When Results Can Be Misleading

Several factors can distort a single reading:

  • Incomplete collection: missing the first or last urine of the 24-hour window throws off every value the index uses. A study of collection accuracy found that younger age, male sex, and Black race were associated with reduced collection accuracy, suggesting careful instructions matter for everyone but especially for these groups.
  • Recent diet shifts: a few days of unusually high salt, protein, or alkali intake before the test can move the number without reflecting your usual chemistry.
  • Acute illness or hospitalization: changes in fluid balance, kidney function, and nutrition during illness can produce results that do not represent your steady state.
  • Drug effects on urine chemistry: proton pump inhibitors lower urinary citrate, calcium, and magnesium and shift stone risk in complex ways. The result reflects the drug's effect on chemistry as much as your baseline biology.

How This Differs From Routine Lab Tests

A standard chemistry panel measures calcium and phosphate in your blood. Those values can look completely normal while your urine is actively saturating with calcium phosphate. The supersaturation index is built specifically to catch what blood chemistry misses: the chemistry happening downstream, in the actual fluid where stones form. If you have had stones or are at risk, this test answers a question your serum panel cannot.

What Moves This Biomarker

Evidence-backed interventions that affect your Calcium Phosphate Saturation level

↓ Decrease
Drink more water to increase urine volume
Diluting your urine is the simplest and most consistent way to lower calcium phosphate supersaturation. In a cohort of stone formers, increasing fluid intake combined with sodium restriction and thiazide therapy lowered urine supersaturation values. More water means lower concentration of every mineral in your urine, which directly reduces the saturation index.
LifestyleStrong Evidence
↓ Decrease
Parathyroidectomy for primary hyperparathyroidism
Surgically removing an overactive parathyroid gland directly addresses the underlying driver of high urine calcium. In a study of patients with primary hyperparathyroidism, parathyroidectomy lowered calcium phosphate supersaturation along with reductions in urinary calcium and calcium oxalate supersaturation. This is the definitive treatment when the parathyroid is the source of the problem.
MedicationStrong Evidence
↓ Decrease
Thiazide diuretic plus low sodium intake
Thiazide medications lower the amount of calcium your kidneys excrete, and combining them with reduced sodium intake amplifies the effect. In stone formers, this combination was associated with reductions in calcium phosphate supersaturation alongside lower urine calcium. This is one of the standard first-line interventions for recurrent calcium stone formers.
MedicationModerate Evidence
↕ Up & Down
Potassium citrate supplementation
Potassium citrate raises urinary citrate (which inhibits crystal formation) and lowers urine calcium, but it also raises urine pH, which on its own pushes calcium phosphate supersaturation up. The net effect depends on your starting chemistry. In a small randomized trial in calcium phosphate stone formers, potassium citrate increased citrate excretion and lowered urine calcium, while plain citric acid did not significantly change urine composition. For calcium phosphate stone formers specifically, this medication needs careful monitoring.
MedicationModerate Evidence
↓ Decrease
SGLT2 inhibitor (such as empagliflozin or dapagliflozin)
These diabetes medications increase urine volume and citrate while lowering urine pH, which together push calcium phosphate supersaturation down. In a cross-sectional analysis of stone formers, SGLT2 inhibitor users had a lower median calcium phosphate supersaturation than non-users. A randomized trial in non-diabetic stone formers (empagliflozin) reported reduced urinary stone recurrence risk markers.
MedicationModerate Evidence
↑ Increase
Higher intake of foods that produce alkali (fruits and vegetables)
Net gastrointestinal alkali absorption raises urine pH and citrate, but it also pushes calcium phosphate supersaturation higher because the more alkaline environment favors calcium phosphate crystal formation. In a large study of adults, higher net alkali absorption was linked to higher calcium phosphate supersaturation alongside higher pH and citrate. This does not mean you should stop eating fruits and vegetables, but if you are a calcium phosphate stone former, the chemistry trade-off matters.
DietModest Evidence
↑ Increase
High chronic intake of fructose and sucrose
Long-term high consumption of free and total fructose and sucrose is associated with slightly higher calcium phosphate supersaturation despite lower urine calcium, based on data from a large adult cohort. The mechanism appears to involve changes in urine chemistry beyond just calcium excretion.
DietModest Evidence

Frequently Asked Questions

References

20 studies
  1. Prochaska M, Taylor E, Ferraro PM, Curhan GThe Journal of Urology2017
  2. Sui W, Calvert J, Kavoussi NL, Gould ER, Miller N, Bejan C, Hsi RJournal of Endourology2020
  3. Berger a, Wu W, Eisner B, Cooperberg M, Duh Q, Stoller MThe Journal of Urology2009
  4. Doizi S, Poindexter J, Pearle M, Blanco F, Moe O, Sakhaee K, Maalouf NThe Journal of Urology2018